Similarly, high serum endolipin and visfatin levels were linked to advanced tumor stage, greater tumor size, and poor outcomes in breast cancer patients, thus serving as a prognostic biomarker in breast cancer survival [85]. Here, NAMPT is linked to breast carcinoma.